Startups

Freedom Biosciences logo

Freedom Biosciences

Freedom Biosciences develops ketamine and psychedelic-based drug regimens for neuropsychiatric disorders, with a focus on improving durability and safety.

Team

Dina BurkitbayevaCo-founder and CEO
John KrystalCo-founder
Timothy WhitakerChief Medical Officer

Investments

$—Unknown datePsyMed Ventures